Skip to content
Home/Companies/Biotech/Micthera
Micthera

Micthera

Biotech·Italy·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Micthera?

Micthera is currently owned by Indaco Venture Partners SGR through Indaco BIO (2022 vintage), since 2024.

Hand-verified · updated 2026-07-23

Indaco Venture Partners SGR
Investor
Indaco Venture Partners SGR
Indaco BIO · 2022 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive
Websitewww.micthera.com

More from Indaco BIO

Other portfolio companies in the same fund.

IAMA Therapeutics
Active
BiotechItaly· 2025
Tes Pharma
Tes Pharma
Active
PharmaItaly· 2025
Valo Therapeutics
Valo Therapeutics
Active
BiotechFinland· 2025
Genespire
Genespire
Active
BiotechItaly· 2024
Freya Biosciences
Freya Biosciences
Active
BiotechDenmark· 2023
Hoba Therapeutics
Active
BiotechSwitzerland· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Micthera

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Micthera?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Micthera.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue